SEARCH:
Print Text size Comment
Email this
Clinical Trials Update: Oct. 21, 2009

The form has errors highlighted in red, please review these entries and try again!



(Separate multiple addresses with commas)




privacy policy | visitor agreement

Clinical Trials Update: Oct. 21, 2009



HealthDay News

Wednesday, October 21, 2009

Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Migraine

This study will evaluate an investigational medication to treat migraines. You must have a history of migraines for at least a year and have more than one migraine episode per month, but not more than 15 migraine days per month, to qualify.

The research site is in Los Alamitos, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.

-----

Chronic Low Back Pain

This is a study of chronic low back pain for adults 18 and older.

The research site is in Beaumont, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/back_pain.aspx.

-----

Parkinson's Disease

This study will evaluate the safety and effectiveness of an experimental treatment to reduce motor symptoms in people with advanced Parkinson's disease.

The research site is in Boston, Mass.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/parkinsons_disease.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

INSIDE LIFE & MARQUEE

Church Notes
Faith and fellowship

Calendar follows local congregations' many activities.


Over 6 million items at your fingertips! Enter a keyword or highlight a category to search or browse at your leisure!
Search by Category

Rocky Mount Telegram | Weather | Sports | Life | Business News | Opinions | Classifieds | Sitemap
Rocky Mount Cars | Rocky Mount Jobs | Rocky Mount Real Estate

Copyright 2009 Rocky Mount Telegram All rights reserved. - Rocky Mount Telegram - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy. About our ads.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ